← All trials
NCT02646397
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2016
- Primary completion
- Dec 1, 2017
- Completion date
- Dec 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 508
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Second Military Medical UniversityLead sponsor
- Second Military Medical UniversityReponsible party - principal investigator
- Southeast UniversityCollaborator
- Sichuan UniversityCollaborator
- Zhejiang UniversityCollaborator
- Anhui College of Traditional Chinese MedicineCollaborator
- Dalian Medical UniversityCollaborator
- Zhengzhou UniversityCollaborator
- Second Military Medical UniversityStudy chair
- Jiao Tong UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.